BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 7724180)

  • 1. Perfluorocarbon liquid in the management of retinal detachment with proliferative vitreoretinopathy.
    Coll GE; Chang S; Sun J; Wieland MR; Berrocal MH
    Ophthalmology; 1995 Apr; 102(4):630-8; discussion 638-9. PubMed ID: 7724180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study.
    Scott IU; Flynn HW; Murray TG; Feuer WJ;
    Am J Ophthalmol; 2003 Sep; 136(3):454-63. PubMed ID: 12967798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and complications associated with giant retinal tear management using perfluoro-n-octane.
    Scott IU; Murray TG; Flynn HW; Feuer WJ; Schiffman JC;
    Ophthalmology; 2002 Oct; 109(10):1828-33. PubMed ID: 12359602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of complex retinal detachment with combined relaxing retinotomy and intravitreal perfluoro-n-octane injection.
    Han DP; Rychwalski PJ; Mieler WF; Abrams GW
    Am J Ophthalmol; 1994 Jul; 118(1):24-32. PubMed ID: 8023872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for retention of subretinal perfluorocarbon liquid in vitreoretinal surgery.
    Garcia-Valenzuela E; Ito Y; Abrams GW
    Retina; 2004 Oct; 24(5):746-52. PubMed ID: 15492629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of short-term postoperative perfluoro-n-octane tamponade for pediatric complex retinal detachment.
    Imaizumi A; Kusaka S; Noguchi H; Shimomura Y; Sawaguchi S
    Am J Ophthalmol; 2014 Feb; 157(2):384-389.e2. PubMed ID: 24332376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pars plana vitrectomy with medium-term postoperative perfluoro-N-octane for recurrent inferior retinal detachment complicated by advanced proliferative vitreoretinopathy.
    Sigler EJ; Randolph JC; Calzada JI; Charles S
    Retina; 2013 Apr; 33(4):791-7. PubMed ID: 23117281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anterior proliferative vitreoretinopathy in the silicone study. Silicone Study Report Number 10.
    Diddie KR; Azen SP; Freeman HM; Boone DC; Aaberg TM; Lewis H; Radtke ND; Ryan SJ
    Ophthalmology; 1996 Jul; 103(7):1092-9. PubMed ID: 8684799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of relaxing retinotomy on surgical outcomes in proliferative vitreoretinopathy.
    Tseng JJ; Barile GR; Schiff WM; Akar Y; Vidne-Hay O; Chang S
    Am J Ophthalmol; 2005 Oct; 140(4):628-36. PubMed ID: 16226515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perfluoro-octane in the treatment of giant retinal tears with proliferative vitreoretinopathy.
    Glaser BM; Carter JB; Kuppermann BD; Michels RG
    Ophthalmology; 1991 Nov; 98(11):1613-21. PubMed ID: 1800921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inferior retinotomy and silicone oil tamponade for recurrent inferior retinal detachment and grade C PVR in eyes previously treated with pars plana vitrectomy or scleral buckle.
    Mancino R; Aiello F; Ciuffoletti E; Di Carlo E; Cerulli A; Nucci C
    BMC Ophthalmol; 2015 Dec; 15():173. PubMed ID: 26645589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of perfluoro-octane in the management of giant retinal tears without proliferative vitreoretinopathy.
    Ie D; Glaser BM; Sjaarda RN; Thompson JT; Steinberg LE; Gordon LW
    Retina; 1994; 14(4):323-8. PubMed ID: 7817025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic utility of the Silicone Study Classification System. Silicone Study Report 9. Silicone Study Group.
    Lean J; Azen SP; Lopez PF; Qian D; Lai MY; McCuen B
    Arch Ophthalmol; 1996 Mar; 114(3):286-92. PubMed ID: 8600888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservation of anterior capsule during vitrectomy and lensectomy for retinal detachment with proliferative vitreoretinopathy.
    MacCumber MW; Packo KH; Civantos JM; Greenberg JB
    Ophthalmology; 2002 Feb; 109(2):329-33. PubMed ID: 11825819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone Study report 11.
    Abrams GW; Azen SP; McCuen BW; Flynn HW; Lai MY; Ryan SJ
    Arch Ophthalmol; 1997 Mar; 115(3):335-44. PubMed ID: 9076205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinotomies of 180 degrees or more.
    Bovey EH; De Ancos E; Gonvers M
    Retina; 1995; 15(5):394-8. PubMed ID: 8594631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfluoroperhydrophenanthrene versus perfluoro-n-octane in vitreoretinal surgery.
    Loewenstein A; Humayun MS; de Juan E; Campochiaro PA; Haller JA
    Ophthalmology; 2000 Jun; 107(6):1078-82. PubMed ID: 10857826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of perfluorocarbon liquids in vitreoretinal surgery.
    Crafoord S; Larsson J; Hansson LJ; Carlsson JO; Stenkula S
    Acta Ophthalmol Scand; 1995 Oct; 73(5):442-5. PubMed ID: 8751125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative Perfluro-N-Octane tamponade for complex retinal detachment surgery.
    Reza AT
    Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):63-9. PubMed ID: 26415342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ENDOSCOPY-ASSISTED VITRECTOMY AND MEMBRANE DISSECTION OF ANTERIOR PROLIFERATIVE VITREORETINOPATHY FOR CHRONIC HYPOTONY AFTER PREVIOUS RETINAL DETACHMENT REPAIR.
    Lee GD; Goldberg RA; Heier JS
    Retina; 2016 Jun; 36(6):1058-63. PubMed ID: 26562564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.